we were the first company to produce inhaler preparations in Thailand and the South-East Asian region
In Conversation
Unlike oncology, the inhalation market in China is far less crowded and developed
[Taiwan] is an interesting market despite sometimes being forgotten and there is plenty of space here for French industry, products and services
I did not want to work on an antibody similar to the dozens already in clinical trials, I wanted to find a differentiator!
Here, university researchers retain the intellectual property rights to their discoveries and inventions. As a result, universities are incentivized to help turn inventions into innovations, and…
As Puerto Rico is one the largest manufacturing hub in pharma and biotech, it is critical for us to be here and keep up with the…
Like many other Big Pharma companies, the global corporate organization has traditionally been more US- and Euro-centric but today, it needs to be more China-centric.
We are working on developing technologies and products to support public health, improve efficiency in healthcare budgeting and deal with emerging diseases.
One significant service which makes us a little unique from other bilateral German chambers is a strong focus on vocational training and education.
What McKinsey brings to the table is a globalized view combined with deep local expertise.
Amgen’s key priority is to broaden the access of our products for the benefit of patients.
I am truly convinced that Thailand can do better and better in diabetes care. And the community is ready to actually change in order to reduce…
